{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T18:31:41Z","timestamp":1766341901436},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[1992,1]]},"DOI":"10.1093\/ajcn\/55.1.203s","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T21:33:11Z","timestamp":1515187991000},"page":"203S-205S","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Clinical studies with phenylpropanolamine: a metaanalysis"],"prefix":"10.1016","volume":"55","author":[{"given":"FL","family":"Greenway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/55.1.203s_bib1","series-title":"Obesity in perspective","article-title":"Review of amphetamine like drugs by the Federal Drug Administration: clinical data and value judgments","author":"Scoville","year":"1973"},{"year":"1986","series-title":"Phenylpropanolamine: a critical analysis of reported adverse reactions and over-dosage","author":"Morgan","key":"10.1093\/ajcn\/55.1.203s_bib2"},{"key":"10.1093\/ajcn\/55.1.203s_bib3","series-title":"Phenylpropanolamine: risks, benefits and controversies","first-page":"53","article-title":"Phenylpropanolamine as an anorexiant agent weight control: a review of published and unpublished studies","author":"Weintraub","year":"1985"},{"key":"10.1093\/ajcn\/55.1.203s_bib4","first-page":"549","article-title":"Three controlled trials of weight loss with phenylpropanolamine","volume":"6","author":"Altschuler","year":"1982","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/55.1.203s_bib5","first-page":"74","article-title":"Effects of phenylpropanolamine, hydrochloride in overweight patients with controlled stable hypertension","volume":"46","author":"Bradley","year":"1989","journal-title":"Curr Ther Res"},{"key":"10.1093\/ajcn\/55.1.203s_bib6","first-page":"584","article-title":"A double-blind clinical evaluation of the anorectic activity of phenylpropanolamine versus placebo","volume":"11","author":"Greenway","year":"1989","journal-title":"Clin Ther"},{"key":"10.1093\/ajcn\/55.1.203s_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/clpt.1986.87","article-title":"Phenylpropanolamine OROS (Acutrim) versus placebo in combination with caloric restriction and physician managed behavior modification","volume":"39","author":"Weintraub","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/55.1.203s_bib8","first-page":"405","article-title":"Effectiveness of phenylpropanolamine (PPA) as an adjunct in the dietary management of obesity","volume":"13","author":"Schteingart","year":"1989","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/55.1.203s_bib9","first-page":"635","article-title":"The use of fluoxetine, a selective serotonin uptake inhibitor in the treatment of obesity, a dose response study","volume":"13","author":"Levine","year":"1989","journal-title":"Int J Obes"},{"year":"1988","series-title":"Phenylpropanolamine, a review","author":"Lasagna","key":"10.1093\/ajcn\/55.1.203s_bib10"},{"key":"10.1093\/ajcn\/55.1.203s_bib11","first-page":"123","article-title":"The treatment of exogenous obesity by medicated benzocaine candy: a double blind placebo study","volume":"10","author":"Collipp","year":"1981","journal-title":"Obes Bariatric Med"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523315314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523315314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/55\/1\/203S\/24066007\/203s.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:28:12Z","timestamp":1727458092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523315314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,1]]}},"alternative-id":["S0002916523315314"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/55.1.203s","relation":{},"ISSN":["0002-9165"],"issn-type":[{"type":"print","value":"0002-9165"}],"subject":[],"published":{"date-parts":[[1992,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical studies with phenylpropanolamine: a metaanalysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/55.1.203s","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 American Society for Nutrition. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}